AFLAC (AFL) Earning Somewhat Favorable News Coverage, Report Finds

Media stories about AFLAC (NYSE:AFL) have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. AFLAC earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 46.9288496024668 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media stories that may have effected Accern’s rankings:

AFLAC opened at $45.00 on Wednesday, according to Marketbeat. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.22. The company has a market cap of $35.42 billion, a P/E ratio of 13.24, a PEG ratio of 1.77 and a beta of 0.93. AFLAC has a 1 year low of $38.31 and a 1 year high of $46.19.

AFLAC (NYSE:AFL) last posted its quarterly earnings results on Wednesday, April 25th. The financial services provider reported $1.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.08. The business had revenue of $5.46 billion for the quarter, compared to analyst estimates of $5.48 billion. AFLAC had a net margin of 20.61% and a return on equity of 12.39%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the business posted $1.47 EPS. equities analysts expect that AFLAC will post 3.97 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, June 1st. Investors of record on Wednesday, May 23rd were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Tuesday, May 22nd. This represents a $1.04 annualized dividend and a dividend yield of 2.31%. AFLAC’s dividend payout ratio is 30.59%.

A number of brokerages have issued reports on AFL. JPMorgan Chase & Co. decreased their target price on shares of AFLAC to $47.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 27th. Zacks Investment Research upgraded shares of AFLAC from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a research report on Tuesday, April 3rd. Wells Fargo & Co set a $48.00 target price on shares of AFLAC and gave the stock a “hold” rating in a research report on Wednesday, April 25th. Barclays decreased their target price on shares of AFLAC to $45.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 21st. Finally, Credit Suisse Group began coverage on shares of AFLAC in a research report on Wednesday, April 25th. They set a “neutral” rating and a $49.00 target price on the stock. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating, three have given a buy rating and two have given a strong buy rating to the stock. AFLAC has a consensus rating of “Hold” and a consensus target price of $46.46.

In related news, Director Charles B. Knapp sold 10,000 shares of the stock in a transaction that occurred on Monday, March 26th. The shares were sold at an average price of $43.72, for a total transaction of $437,200.00. Following the sale, the director now owns 76,582 shares in the company, valued at approximately $3,348,165.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.70% of the company’s stock.

AFLAC Company Profile

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Insider Buying and Selling by Quarter for AFLAC (NYSE:AFL)

Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with's FREE daily email newsletter.

Leave a Reply